In metastatic melanoma, all PD-1 blockade responders showed an increase in TCR clonality due to prior CTLA-4 blockade, however, the effect of anti-CTLA-4 on TME has not been further analyzed18. This evidence concerns the gene CTLA4 and metastatic melanoma.